Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The artificial pancreas market is set to grow by USD 450.95 million from 2021 to 2026, progressing at a CAGR of 19.15% according to the latest.
The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use.Not available for sale. The iLet®.